[Hemostatic disturbances in obesity]
Renata Swiatkowska-Stodulska1, Ewa Kazimierska, Krzysztof Sworczak
1Kliniki Chorób Wewnetrznych, Endokrynologii i Zaburzeń Hemostazy Instytutu Chorób Wewnetrznych Akademii Medycznej w Gdańsku.
Abstract:
Overweight and obesity belong to the group of chronic diseases in which there is a substantially increased risk of thromboembolic incidents. The changes involve both arterial and venous system. The decisive role in their development seems to have disorders ofhemostasis including both excessive activation of coagulation system and/or inhibition of fibrinolysis. Coagulation changes in obese persons are complex. They include, among others, increase in concentration and activity of blood clotting factors, hyperfibrynogenemia and overeactivity ofplatelets. On the other hand, inhibition of normal fibrinolysis occurs in obese persons. The goal of this study was to examine disorders of coagulation and fibrinolysis developing in obese persons, taking also into account hormonal and metabolic changes, endothelium damage and the influence of adipocytokines on the hemostasis mechanisms.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
